Celldex/$CLDX
About Celldex
Ticker
Industry
Employees
Celldex Metrics
$1.5B
-
-$2.53
1.59
-
Price and volume
Market cap
$1.5B
Beta
1.59
52-week high
$53.18
52-week low
$22.88
Average daily volume
1M
Financial strength
Current ratio
24.268
Quick ratio
23.583
Long term debt to equity
0.217
Total debt to equity
0.393
Management effectiveness
Return on assets (TTM)
-19.73%
Return on equity (TTM)
-29.84%
Valuation
Price to revenue (TTM)
139.856
Price to book
1.94
Price to tangible book (TTM)
2.01
Price to free cash flow (TTM)
-8.738
Growth
Revenue change (TTM)
128.55%
Earnings per share change (TTM)
-4.15%
3-year revenue growth (CAGR)
7.18%
3-year earnings per share growth (CAGR)
12.95%
What the Analysts think about Celldex
Analyst Ratings
Celldex Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
Celldex Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
Celldex News
Celldex Initiates Phase 2 Study of Barzolvolimab in Atopic Dermatitis
Celldex Announces First Patient Dosed in Phase 1 Healthy Volunteer Study of CDX-622, a Bispecific Antibody, for the Treatment of Inflammatory Diseases
Celldex Therapeutics to Present at Upcoming Investor Conferences
FAQs
What’s the current market cap for Celldex stock?
What is the P/E ratio for Celldex stock?
Does Celldex stock pay dividends?
No, Celldex (CLDX) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Celldex dividend payment date?
Celldex (CLDX) stock does not pay dividends to its shareholders.
What is the beta indicator for Celldex?
Celldex (CLDX) has a beta rating of 1.59. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.